|
Name |
Globosuxanthone A
|
| Molecular Formula | C15H12O7 | |
| IUPAC Name* |
methyl (1R,2R)-1,2,8-trihydroxy-9-oxo-2H-xanthene-1-carboxylate
|
|
| SMILES |
COC(=O)[C@@]1([C@@H](C=CC2=C1C(=O)C3=C(C=CC=C3O2)O)O)O
|
|
| InChI |
InChI=1S/C15H12O7/c1-21-14(19)15(20)10(17)6-5-9-12(15)13(18)11-7(16)3-2-4-8(11)22-9/h2-6,10,16-17,20H,1H3/t10-,15+/m1/s1
|
|
| InChIKey |
HEFOWMGZUBJFBY-BMIGLBTASA-N
|
|
| Synonyms |
Globosuxanthone A; MLS004257380; CHEBI:68712; SMR003082512; HY-125727; CS-0093427; Q27137132; 1R*,2R*,8-trihydroxanthenone-1-carboxylic acid methyl ester; methyl (1R,2R)-1,2,8-trihydroxy-9-oxo-2H-xanthene-1-carboxylate; rel-methyl (1R,2R)-1,2,8-trihydroxy-9-oxo-2,9-dihydro-1H-xanthene-1-carboxylate
|
|
| CAS | NA | |
| PubChem CID | 16046111 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 304.25 | ALogp: | 1.1 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 113.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 22 | QED Weighted: | 0.662 |
| Caco-2 Permeability: | -4.796 | MDCK Permeability: | 0.00001560 |
| Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.143 |
| Human Intestinal Absorption (HIA): | 0.021 | 20% Bioavailability (F20%): | 0.012 |
| 30% Bioavailability (F30%): | 0.125 |
| Blood-Brain-Barrier Penetration (BBB): | 0.597 | Plasma Protein Binding (PPB): | 80.83% |
| Volume Distribution (VD): | 0.961 | Fu: | 23.93% |
| CYP1A2-inhibitor: | 0.383 | CYP1A2-substrate: | 0.938 |
| CYP2C19-inhibitor: | 0.258 | CYP2C19-substrate: | 0.653 |
| CYP2C9-inhibitor: | 0.183 | CYP2C9-substrate: | 0.357 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.216 |
| CYP3A4-inhibitor: | 0.231 | CYP3A4-substrate: | 0.737 |
| Clearance (CL): | 0.86 | Half-life (T1/2): | 0.794 |
| hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.819 |
| Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.614 |
| Rat Oral Acute Toxicity: | 0.185 | Maximum Recommended Daily Dose: | 0.056 |
| Skin Sensitization: | 0.336 | Carcinogencity: | 0.027 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.03 |
| Respiratory Toxicity: | 0.046 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004884 | ![]() |
1.000 | D0K8KX | ![]() |
0.277 | ||
| ENC004138 | ![]() |
0.718 | D0E3OF | ![]() |
0.263 | ||
| ENC004286 | ![]() |
0.627 | D07MGA | ![]() |
0.260 | ||
| ENC004284 | ![]() |
0.603 | D04AIT | ![]() |
0.255 | ||
| ENC002954 | ![]() |
0.603 | D06GCK | ![]() |
0.252 | ||
| ENC004886 | ![]() |
0.475 | D08QJS | ![]() |
0.252 | ||
| ENC004885 | ![]() |
0.468 | D0S0LZ | ![]() |
0.252 | ||
| ENC002283 | ![]() |
0.468 | D0H1AR | ![]() |
0.252 | ||
| ENC004287 | ![]() |
0.457 | D0J2NK | ![]() |
0.248 | ||
| ENC002469 | ![]() |
0.424 | D0Z3DY | ![]() |
0.247 | ||